PL4404916T3 - Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie - Google Patents
Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanieInfo
- Publication number
- PL4404916T3 PL4404916T3 PL22790469.5T PL22790469T PL4404916T3 PL 4404916 T3 PL4404916 T3 PL 4404916T3 PL 22790469 T PL22790469 T PL 22790469T PL 4404916 T3 PL4404916 T3 PL 4404916T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- pharmaceutical composition
- nasal
- improved pharmaceutical
- improved
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HRP20211486 | 2021-09-22 | ||
| PCT/EP2022/075786 WO2023046590A1 (en) | 2021-09-22 | 2022-09-16 | An improved pharmaceutical composition for nasal use, preparation, and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4404916T3 true PL4404916T3 (pl) | 2025-12-08 |
Family
ID=83898344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22790469.5T PL4404916T3 (pl) | 2021-09-22 | 2022-09-16 | Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4404916B1 (pl) |
| ES (1) | ES3039833T3 (pl) |
| PL (1) | PL4404916T3 (pl) |
| WO (1) | WO2023046590A1 (pl) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19549421C2 (de) | 1995-11-10 | 1999-11-18 | Klosterfrau Mcm Vetrieb Gmbh | Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden |
| WO2000078297A2 (de) | 1999-06-22 | 2000-12-28 | Boehringer Ingelheim International Gmbh | Stabile xylometazolin- und oxymetazolinlösung |
| DE10064219B9 (de) * | 2000-12-22 | 2009-02-12 | Nasalis Pain Relief International Gmbh | Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung |
| DE10337186A1 (de) | 2003-08-13 | 2005-03-17 | Merck Patent Gmbh | Wässrige Wirkstoff-Lösung |
| DE20318634U1 (de) | 2003-11-13 | 2004-02-26 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden |
| DE102012005452A1 (de) * | 2011-12-30 | 2013-07-04 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Zusammensetzung für die nasale Applikation mit verbesserter Stabilität |
| CN103705463A (zh) * | 2014-01-14 | 2014-04-09 | 中国药科大学 | 一种鼻用温度敏感型水凝胶喷雾 |
| DE202017104738U1 (de) | 2017-07-31 | 2018-08-01 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue Zusammensetzung für die nasale Applikation |
| ES2972897T3 (es) * | 2017-08-10 | 2024-06-17 | Elixir Ilac Arastirma Ve Gelistirme A S | Composiciones descongestionantes nasales que comprenden mentol, dexpantenol e hialuronato de sodio |
-
2022
- 2022-09-16 PL PL22790469.5T patent/PL4404916T3/pl unknown
- 2022-09-16 EP EP22790469.5A patent/EP4404916B1/en active Active
- 2022-09-16 WO PCT/EP2022/075786 patent/WO2023046590A1/en not_active Ceased
- 2022-09-16 ES ES22790469T patent/ES3039833T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4404916C0 (en) | 2025-08-06 |
| ES3039833T3 (en) | 2025-10-24 |
| EP4404916B1 (en) | 2025-08-06 |
| WO2023046590A1 (en) | 2023-03-30 |
| EP4404916A1 (en) | 2024-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289513A (en) | A pharmaceutical preparation for administration through the nose | |
| SG11202105850YA (en) | Diphenyl-like compound, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and uses thereof | |
| MX2021004110A (es) | Composiciones farmaceuticas que comprenden n-(3,5- dimetoxifenil)-n'-(1-metiletil)-n-[3-(1-metil-1h- pirazol-4-il)quinoxalin-6-il]etano-1,2-diamina. | |
| WO2012074231A3 (ko) | 모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물 | |
| IL287905A (en) | A pharmaceutical preparation containing brexanolone, gnaxolone or zoranolone and its use | |
| IL276244A (en) | A pharmaceutical preparation for the eyes, a method for its preparation and its application | |
| PL3786167T3 (pl) | Diarylowy związek makrocykliczny i kompozycja farmaceutyczna oraz ich zastosowanie | |
| SG11202107848TA (en) | Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereof | |
| EP4053154A4 (en) | KERATIN BD-10, METHOD FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITION THEREOF, AND ITS USE | |
| ZA202105586B (en) | Pharmaceutical delivery compositions and uses thereof | |
| EP3858846A4 (en) | NUCLEIC ACID NANO-CARRIER MEDICINE, METHOD FOR PREPARING IT, PHARMACEUTICAL COMPOSITION THEREOF, AND CORRESPONDING USE | |
| EP4223759A4 (en) | PYRAZOLOPYRIDAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE | |
| IL285277A (en) | History of imidazoquinolines and their use | |
| IL285421B2 (en) | History of indazolyl-isoxazoles, their preparation and pharmaceutical preparations containing them | |
| IL289943A (en) | Medicinal and/or pharmaceutical compositions for insertion into a blister, preparation and uses | |
| GB2590189B (en) | Lycorine derivative, and pharmaceutical composition and use thereof | |
| AU2021413439A9 (en) | Pharmaceutical composition for inhalation | |
| IL210975A (en) | Annapomapungin History, Pharmaceuticals Containing Them and Their Use in Preparing Medicines to Treat Fungal Infections | |
| GB202415076D0 (en) | 5-pyridine-1h-indazole compound, pharmaceutical composition, and use | |
| EP4053155A4 (en) | KERATIN BD-4, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| PL4404916T3 (pl) | Ulepszona kompozycja farmaceutyczna do stosowania donosowego, jej wytwarzanie i stosowanie | |
| CA3261961A1 (en) | Lipoligourates, pharmaceutical composition and lipooligourates intended for use as a medicinal product | |
| PT3650024T (pt) | Composição farmacêutica para administração nasal compreendendo rifampicinas para tratar demência | |
| GB202004832D0 (en) | Therapeutic agaents, pharmaceutical compositions, and associated biomarkers | |
| IL284587A (en) | A pharmaceutical compound containing an antibody, a device containing it, and its use |